Singapore markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
69.13-0.56 (-0.80%)
At close: 04:00PM EDT
69.13 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
486,816
486,816
316,385
216,136
208,475
Cost of revenue
181,513
181,513
138,785
100,610
87,157
Gross profit
305,303
305,303
177,600
115,526
121,318
Operating expenses
Research development
34,286
34,286
22,318
11,369
16,001
Selling general and administrative
161,697
161,697
124,044
84,294
64,986
Total operating expenses
255,774
255,774
203,334
143,695
136,888
Operating income or loss
49,529
49,529
-25,734
-28,169
-15,570
Interest expense
26,940
26,940
28,052
11,922
9,452
Total other income/expenses net
-2,717
-2,717
-8,879
-15,967
-940
Income before tax
19,872
19,872
-62,665
-56,058
-25,962
Income tax expense
1,093
1,093
-14,769
-13,455
-3,414
Income from continuing operations
18,779
18,779
-47,896
-42,603
-22,548
Net income
18,779
18,779
-47,896
-42,603
-22,548
Net income available to common shareholders
17,154
17,154
-49,521
-42,793
-22,548
Basic EPS
0.55
0.86
-3.05
-3.40
-1.88
Diluted EPS
0.54
0.85
-3.05
-3.40
-1.88
Basic average shares
17,329
18,001
16,260
12,596
11,964
Diluted average shares
17,449
18,194
16,260
12,596
11,964